Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

Nov 2022| TBR1484C| TBRC (Publisher)

Report Highlights

Including: 1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
3) By End-User: Hospitals; Research Laboratories
Covering: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc; Takara Bio, Inc; Lonza Group AG; Astellas Pharma Inc

Induced Pluripotent Stem Cell (IPSC) Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market.
  • Key Trends - Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by derived cell type, by application, and by end-user in the market.
  • Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - Includes recommendations for induced pluripotent stem cell (IPSC) providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
  • By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
  • By End-User: Hospitals; Research Laboratories

Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc.; Takara Bio, Inc.; Lonza Group AG; Astellas Pharma Inc.

Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13 : Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 14 : Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 15 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17 : Asia-Pacific, Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 18 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 19 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 20 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 21 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 22 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 23 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 24 : China Population By Age Group, 2016-2026, Thousands
  • Table 25 : China GDP Per Capita, 2016-2021, $
  • Table 26 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 27 : China Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 28 : China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 29 : China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 30 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 31 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 32 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 33 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 34 : India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 35 : India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 36 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 37 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 38 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 41 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 42 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 47 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 48 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 49 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 50 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 53 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 54 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 55 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 56 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 57 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 58 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 59 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 60 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 61 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 62 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 63 : Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 64 : Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 65 : Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 66 : Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 67 : Western Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 68 : Western Smart Europe Washing Machines Market, Historic, 2016 – 2021, $ Million
  • Table 69 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 70 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 71 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 72 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 73 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 74 : UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 75 : UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 76 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 77 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 78 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 79 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 80 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 81 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 82 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 83 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 84 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 85 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 86 : France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 87 : France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 88 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 89 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 90 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 91 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 92 : Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 93 : Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 94 : Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 95 : Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 96 : Eastern Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 97 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 98 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 99 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 100 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 101 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 102 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 103 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 104 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 105 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 106 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 107 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 108 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 109 : North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 110 : North America GDP Per Capita, By Country, 2016-2021, $
  • Table 111 : North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 112 : North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 113 : North America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 114 : North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 115 : North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 116 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 117 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 118 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 119 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 120 : USA Population By Age Group, 2016-2026, Thousands
  • Table 121 : USA GDP Per Capita, 2016-2021, $
  • Table 122 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 123 : USA Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 124 : USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 125 : USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 126 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 127 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 128 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 129 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 130 : South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 131 : South America GDP Per Capita, By Country, 2016-2021, $
  • Table 132 : South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 133 : South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 134 : South America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 135 : South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 136 : South America Washing Machines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 137 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 138 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 139 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 140 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 141 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 142 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 143 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 144 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 145 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 146 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 147 : Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 148 : Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 149 : Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 150 : Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 151 : Middle East Healthcare Services Market Size, 2016-2021, $ Billion
  • Table 152 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Table 153 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 154 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 155 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 156 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 157 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 158 : Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 159 : Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 160 : Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 161 : Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 162 : Africa Healthcare Services Market Size, 2016-2021, $ Billion
  • Table 163 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 164 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 165 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 166 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 167 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 168 : Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 169 : Fujifilm Holding’s – Financial Performance, 2017– 2021, $ Billion
  • Table 170 : Thermo Fisher – Financial Performance, 2017-2021, $ Billion
  • Table 171 : Lonza – Financial Performance, 2017 – 2021, $ Billion
  • Table 172 : Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 173 : Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Derived Cell Type, 2021 – 2026
  • Table 174 : Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
  • Table 175 : Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By End-Use Industry, 2021 – 2026
  • Table 176 : Induced Pluripotent Stem Cell (iPSC) Market Data Sources
  • Figure 1 : Geographic Regions Covered
  • Figure 2 : Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By Derived Cell Type
  • Figure 3 : Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By Derived Cell Type
  • Figure 4 : Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By Derived Cell Type
  • Figure 5 : Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 6 : Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 7 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11 : Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 12 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 13 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 14 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 15 : Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 16 : China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 17 : China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 18 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 19 : China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 20 : India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 21 : India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 22 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 23 : India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 24 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 25 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 26 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 27 : Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 28 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 29 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 30 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 31 : Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 32 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 33 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 34 : Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 36 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 37 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 38 : South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 39 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 40 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 41 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 42 : Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 43 : UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 44 : UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 45 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46 : UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 48 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 49 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51 : France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 52 : France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 53 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 54 : France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 56 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 57 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 58 : Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 60 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 61 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62 : Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 63 : North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 64 : North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 65 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66 : North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 67 : USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 68 : USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 69 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70 : USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71 : South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 72 : South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 73 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 74 : South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 76 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 77 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 78 : Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 79 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2016 – 2021, $ Million
  • Figure 80 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 81 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 82 : Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 83 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 84 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 85 : Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86 : Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 87 : Fujifilm Holding’s – Financial Performance, 2017– 2021, $ Billion
  • Figure 88 : Thermo Fisher – Financial Performance, 2017-2021, $ Billion
  • Figure 89 : Lonza – Financial Performance, 2017 – 2021, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022

  • Date - Feb 2022
  • Code - TBR1484B

Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
3) By End-User: Hospitals; Research Laboratories
Covering: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022 from ...

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

  • Date - Aug 2021
  • Code - TBR1484A

Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic; Others
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Gene & Cell Therapy
3) By End-User: Hospitals; Research Laboratories
Covering: Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc.; ViaCyte; Fate Therapeutics

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2030: COVID-19 ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS